It scared the hell out of me,' says lead plaintiff in proposed class-action suit over data breach at 23andMe Canada, U.K. launch joint privacy probe into 23andMe data breach 23andMe anticipates the job cuts and other restructuring efforts announced Monday ...

Genetic testing firm 23andMe said on Monday it is reducing about 40 per cent, or 200 employees, from its workforce and discontinuing all its therapies.

In June, data watchdogs in the UK and Canada announced investigations into the breach. At the time, a statement from the UK's Information Commissioner's Office said "23andMe is a custodian of highly sensitive personal information, including genetic ...

Genetic testing firm 23andMe said on Monday it is reducing its overall headcount by over 200 employees or about 40% of the workforce, as part of a restructuring program. The company expects annualized cost savings of more than $35 million as a result of the restructuring.

The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price continues to plummet. CBS News correspondent Carter Evans has more on what this means for its customers.

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a restructuring that will see the company also halt the development of its therapeutics division which had been working on various potential medical treatments.

The genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year, and CEO Anne Wojcicki has desperately been trying to right the ship. Now,

More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs will impact 40 percent of the genetic testing companys